Article info
PDFCardiovascular medicine
Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemia
- Correspondence to:
Dr JJP Kastelein, Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, Netherlands;
e.vandongen{at}amc.uva.nl
Citation
Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemia
Publication history
- Accepted May 21, 2002
- First published September 1, 2002.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2002 by Heart